Cargando…

Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)

Background: Few studies have examined the epidemiology of polypharmacy in non-institutionalized elderly adults with regard to sex differences. This study aimed to identify the prevalence of polypharmacy among people ≥65 years old residing in Spain, analyze trends in that prevalence from 2011/12 to 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Cebrino, Jesús, Portero de la Cruz, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160439/
https://www.ncbi.nlm.nih.gov/pubmed/37153776
http://dx.doi.org/10.3389/fphar.2023.1189644
_version_ 1785037278506123264
author Cebrino, Jesús
Portero de la Cruz, Silvia
author_facet Cebrino, Jesús
Portero de la Cruz, Silvia
author_sort Cebrino, Jesús
collection PubMed
description Background: Few studies have examined the epidemiology of polypharmacy in non-institutionalized elderly adults with regard to sex differences. This study aimed to identify the prevalence of polypharmacy among people ≥65 years old residing in Spain, analyze trends in that prevalence from 2011/12 to 2020, describe the use of the medicines involved and study the possible relationship between polypharmacy and certain sociodemographic, health-related variables, as well as the use of care services by sex. Methods: A nationwide cross-sectional study with 21,841 non-institutionalized people ≥65 years old from the Spanish National Health Survey (2011/2012 and 2017) and the European Health Survey in Spain (2014 and 2020) was performed. We used descriptive statistics, performing two binary logistic regressions to determine the factors related to polypharmacy. Results: The prevalence of polypharmacy was 23.2% (women: 28.1%, men: 17.2%; p < 0.001). The most commonly consumed medicines were analgesics and tranquillizers, relaxants or sleeping pills in elderly women, compared with antihypertensives, antacids and antiulcer drugs and statins for elderly men. In both sexs, the positive predictors of polypharmacy included average, poor and very poor self-perceived states of health, people with overweight and obesity, being severely/non-severely limited due to a health problem, having ≥ three chronic conditions, visits to the family doctor and hospitalization. Among elderly women, negative predictors were alcohol intake, whereas in elderly men positive predictors were being 75–84 years old, being current smokers and having 1, 2 chronic conditions. Conclusion: Polypharmacy has a prevalence of 23.2%, with women accounting for 28.1% and men 17.2% of the total. Knowledge of positive and negative predictors of polypharmacy have important implications for public health efforts to develop or improve health guidelines and strategies for promoting the proper use of medication, particularly in the elderly population by sex.
format Online
Article
Text
id pubmed-10160439
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101604392023-05-06 Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020) Cebrino, Jesús Portero de la Cruz, Silvia Front Pharmacol Pharmacology Background: Few studies have examined the epidemiology of polypharmacy in non-institutionalized elderly adults with regard to sex differences. This study aimed to identify the prevalence of polypharmacy among people ≥65 years old residing in Spain, analyze trends in that prevalence from 2011/12 to 2020, describe the use of the medicines involved and study the possible relationship between polypharmacy and certain sociodemographic, health-related variables, as well as the use of care services by sex. Methods: A nationwide cross-sectional study with 21,841 non-institutionalized people ≥65 years old from the Spanish National Health Survey (2011/2012 and 2017) and the European Health Survey in Spain (2014 and 2020) was performed. We used descriptive statistics, performing two binary logistic regressions to determine the factors related to polypharmacy. Results: The prevalence of polypharmacy was 23.2% (women: 28.1%, men: 17.2%; p < 0.001). The most commonly consumed medicines were analgesics and tranquillizers, relaxants or sleeping pills in elderly women, compared with antihypertensives, antacids and antiulcer drugs and statins for elderly men. In both sexs, the positive predictors of polypharmacy included average, poor and very poor self-perceived states of health, people with overweight and obesity, being severely/non-severely limited due to a health problem, having ≥ three chronic conditions, visits to the family doctor and hospitalization. Among elderly women, negative predictors were alcohol intake, whereas in elderly men positive predictors were being 75–84 years old, being current smokers and having 1, 2 chronic conditions. Conclusion: Polypharmacy has a prevalence of 23.2%, with women accounting for 28.1% and men 17.2% of the total. Knowledge of positive and negative predictors of polypharmacy have important implications for public health efforts to develop or improve health guidelines and strategies for promoting the proper use of medication, particularly in the elderly population by sex. Frontiers Media S.A. 2023-04-21 /pmc/articles/PMC10160439/ /pubmed/37153776 http://dx.doi.org/10.3389/fphar.2023.1189644 Text en Copyright © 2023 Cebrino and Portero de la Cruz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Cebrino, Jesús
Portero de la Cruz, Silvia
Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
title Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
title_full Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
title_fullStr Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
title_full_unstemmed Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
title_short Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
title_sort polypharmacy and associated factors: a gender perspective in the elderly spanish population (2011–2020)
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160439/
https://www.ncbi.nlm.nih.gov/pubmed/37153776
http://dx.doi.org/10.3389/fphar.2023.1189644
work_keys_str_mv AT cebrinojesus polypharmacyandassociatedfactorsagenderperspectiveintheelderlyspanishpopulation20112020
AT porterodelacruzsilvia polypharmacyandassociatedfactorsagenderperspectiveintheelderlyspanishpopulation20112020